InflaRx (IFRX) Total Current Liabilities (2016 - 2026)

InflaRx has disclosed Total Current Liabilities across 11 years of filings, most recently posting $13.3 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $13.3 million, down 21.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.3 million (down 21.75% YoY), and the FY2025 annual result was $15.1 million, changed 0.18% from the prior year.
• Total Current Liabilities came in at $13.3 million for Q1 2026 at InflaRx, down from $15.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $22.3 million in Q3 2025 to a low of $7.3 million in Q1 2023.
• The 5-year median for Total Current Liabilities is $13.3 million (2026), against an average of $14.3 million.
• Across the five-year window, Total Current Liabilities jumped 114.31% in 2022 and sank 65.69% in 2023, its largest moves.
• InflaRx's Total Current Liabilities stood at $13.3 million in 2022, then surged by 36.37% to $18.1 million in 2023, then fell by 16.47% to $15.1 million in 2024, then declined by 0.18% to $15.1 million in 2025, then retreated by 11.75% to $13.3 million in 2026.
• The last three Total Current Liabilities figures came in at $13.3 million (Q1 2026), $15.1 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.